The challenge of type 1 diabetes mellitus

被引:42
作者
Eiselein, L [1 ]
Schwartz, HJ
Rutledge, JC
机构
[1] Univ Calif Davis, Mol Cellular & Integrat Physiol Grad Grp, Davis, CA 95616 USA
[2] Univ Calif Davis, Sch Med, Dept Med, Div Endocrinol Clin Nutr & Vasc Med, Davis, CA 95616 USA
关键词
complications; diagnosis; pathology; therapy; type; 1; diabetes;
D O I
10.1093/ilar.45.3.231
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Diabetes mellitus is a heterogeneous group of diseases characterized by high blood glucose levels due to defects in insulin secretion, insulin action, or both. With the number of cases expected to increase rapidly in the years to come, diabetes is a growing health challenge worldwide. Of the approximately 16 million diabetics in the United States, about 1.5 million suffer from type 1 diabetes. In this catabolic disorder afflicting predominantly young individuals, blood insulin is almost completely absent, leading to hyperglycemia and alterations in lipid metabolism. Type 1 diabetes is thought to be induced by a toxic or infectious insult that occurs in genetically predisposed individuals. With recent advances in the understanding of the involved immunology and cellular and molecular mechanisms, researchers strive to battle the disease with new preventive and corrective strategies.
引用
收藏
页码:231 / 236
页数:6
相关论文
共 52 条
[21]   Advanced glycation end products and their recognition by macrophage and macrophage-derived cells [J].
Horiuchi, S ;
Higashi, T ;
Ikeda, K ;
Saishoji, T ;
Jinnouchi, Y ;
Sano, H ;
Shibayama, R ;
Sakamoto, T ;
Araki, N .
DIABETES, 1996, 45 :S73-S76
[22]   Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor [J].
Ishii, H ;
Jirousek, MR ;
Koya, D ;
Takagi, C ;
Xia, P ;
Clermont, A ;
Bursell, SE ;
Kern, TS ;
Ballas, LM ;
Heath, WF ;
Stramm, LE ;
Feener, EP ;
King, GL .
SCIENCE, 1996, 272 (5262) :728-731
[23]  
Jinnouchi Y, 1998, J BIOCHEM-TOKYO, V123, P1208
[24]   AUTOIMMUNITY TO 2 FORMS OF GLUTAMATE-DECARBOXYLASE IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
KAUFMAN, DL ;
ERLANDER, MG ;
CLARESALZLER, M ;
ATKINSON, MA ;
MACLAREN, NK ;
TOBIN, AJ .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (01) :283-292
[25]  
KING H, 1998, DIABETES CARE, V21, P1212
[26]   High glucose-induced transforming growth factor β1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells [J].
Kolm-Litty, V ;
Sauer, U ;
Nerlich, A ;
Lehmann, R ;
Schleicher, ED .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (01) :160-169
[27]   Protein kinase C activation and the development of diabetic complications [J].
Koya, D ;
King, GL .
DIABETES, 1998, 47 (06) :859-866
[28]   Commentary - Autoimmunity and diabetes [J].
Kukreja, A ;
MaClaren, NK .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (12) :4371-4378
[29]   The Deutsche Nicotinamide Intervention Study - An attempt to prevent type 1 diabetes [J].
Lampeter, EF ;
Klinghammer, A ;
Scherbaum, WA ;
Heinze, E ;
Haastert, B ;
Giani, G ;
Kolb, H .
DIABETES, 1998, 47 (06) :980-984
[30]   The role of protein kinase C in the pathophysiology of diabetic retinopathy [J].
Lang, GE ;
Kampmeier, J .
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2002, 219 (11) :769-776